Knights Group Holdings PLC (KGH) — Investment Research Note

Executive summary

Knights is the UK's leading corporatised consolidator of regional legal services outside London, operating from 29 offices with ~1,663 people and FY26 revenue of £207.7m. Since IPO in 2018 the group has grown underlying EBITDA more than sixfold via 29 acquisitions plus organic hiring, delivering 28% revenue growth and 19% underlying PBT growth in FY26 2026-07 FY results, though headline profits and organic growth were held back historically by a March 2022 profit warning (Omicron + macro slowdown). The single most important valuation point is the persistent gap between reported PBT (£10.2m) and underlying PBT (£33.2m) driven by ~£17.9m of "non-underlying" costs — much of it real cash (contingent acquisition payments treated as remuneration under IFRS) — which means investors must decide how much of "underlying" earnings is truly recurring.

Fair value estimate

• Range: 200p – 275p per share → implied market cap £172m – £237m (86.0m shares)
• Mid: ~235p / ~£202m market cap
• Methodology: multiple of forward underlying earnings, cross-checked against EV/EBITDA
  • FY26 underlying EPS 28.14p 2026-07 FY results; FY27 likely 30-33p including Moore Barlow (£30m revenue at anticipated 18% PBT margin post synergies) 2026-08 Moore Barlow announcement and full-year contribution of THP + IBB
  • Applied 7-9x forward underlying EPS (reflects consolidator model with acquisition execution risk, contingent consideration cash drag, and modest organic growth track record). UK legal services peers Gateley and Keystone Law trade at ~8-12x underlying earnings
  • EV/EBITDA cross-check: FY26 underlying EBITDA £51.5m, FY27 estimate ~£58m; at 5-6.5x EV/EBITDA gives EV £290m-£377m; less net debt £65.4m → equity £225m-£312m
  • I strip out contingent consideration (~£8-9m annualised) as a real economic cost when sizing sustainable earnings — this justifies the conservative multiple
• Current market cap £144.9m (168.5p) implies significant discount to mid; upside to mid 40% (+66p); upside to top of range ~63%

Sector context

• Sector confirmed: Industrial Goods and Services (professional services). ICB classification is arguably peculiar — Knights is really a Financial/Business Services firm — but that's the industry framework as given.
• Quality/growth/leverage profile: revenue growth (28%) is well above typical UK professional services peers; underlying PBT margin (16%) is in line with quality peers; balance sheet (1.5x net debt/EBITDA) is towards the higher end for a services business
• Listed peers: Gateley Holdings (GTLY, larger PLC law firm consolidator), Keystone Law Group (KEYS, platform model), and historically DWF (taken private 2024)

Investment thesis (3 bullets)

1. Structural consolidation opportunity in a highly fragmented UK regional legal market, with Knights positioned as the acquirer of choice — 29 acquisitions completed, fresh £159m RCF (up from £100m) committed until July 2029 provides ample firepower 2026-07 FY results. Post-year-end Moore Barlow (£30m revenue), THP, and Mayfair Property Law acquisitions extend reach in affluent South East 2026-08 acquisition announcements.
2. Return to double-digit organic growth in H2 FY26 (12% vs 2.6% H1), demonstrating that the platform, once integrated acquisitions are onboarded, can deliver both acquisitive and organic growth. Churn now at 10% (below industry average) with strong recruitment momentum (39 senior recruits in FY26) 2026-07 FY results.
3. Modest valuation relative to underlying earnings power — at 168.5p the shares trade on ~6x FY26 underlying EPS of 28.14p and ~4.1x EV/EBITDA, well below both UK peers and the group's own historical multiples, offering fair upside even on conservative assumptions.

Key risks (3 bullets)

1. Persistent gap between reported and underlying earnings — non-underlying costs of £17.9m in FY26 (£11.7m in FY25) include £8.1m contingent acquisition payments which are real cash outflows treated as remuneration, plus recurring transaction, restructuring and lease impairment charges. If the acquisition machine slows, these "non-underlying" costs will naturally fall but organic growth must accelerate to fill the gap 2026-07 FY results notes 13, 39.
2. AI substitution risk at the lower end of legal services — as agentic AI matures, commodity legal work (residential conveyancing at Integrar, standardised drafting, some private client work) faces margin pressure. Knights' "security-first approach" AI initiative is defensive, not a value creator 2026-01 half-year results, 2026-07 FY results.
3. Related-party lease with CEO — the group leases its Newcastle-under-Lyme central hub from KPV Propco Ltd, a company controlled by CEO David Beech, at £801k p.a. for a 25-year term signed December 2024 2026-07 FY results note 43. Not a disqualifier but a governance flag for corporate scale-up.

Operating leverage

Knights has moderate operating leverage — meaningfully weaker than the "software / platform" model. FY26 employee costs of £126.3m are 60.8% of revenue (up from 60.3%), and while central Business Services costs are more fixed (technology platform, CTO office, Client Services Directors), the direct fee-earner cost line moves closely with revenue. The FY26 EBITDA margin actually declined 170bps (26.5% → 24.8%) despite 28% revenue growth, with management attributing the drop to higher NI, lower client interest income, and AI/technology investment 2026-07 FY results CFO review. This is the opposite of true operating leverage. That said, the platform is genuinely scalable — property costs fell from 4.6% to 4.2% of revenue as portfolio was leveraged, and the fee earner to non-fee-earner ratio improved (3.7:1 → 3.9:1). A 10-20% organic revenue surprise would likely deliver ~30-50% incremental EBITDA margin (i.e. ~£15-30m incremental revenue → ~£5-12m incremental EBITDA), meaningful but not transformative. This is not a stock where an upside revenue surprise multiplies profits.

Value-trap signals

• Contingent consideration structure creates a permanent "non-underlying" drag — £8.1m FY26 (£3.8m FY25) charged as remuneration, with ~£9.3m still to unwind. This is real economic cost that acquisitive investors accept as the price of the model.
• Reported EPS trajectory declining (11.47p → 8.83p → 5.40p) even as underlying EPS rises, reflecting escalating non-underlying costs from the acquisition programme.
• March 2022 profit warning on Omicron impact; broader macro slowdowns disproportionately affect transactional work (residential property, M&A).
• Not classic value-trap signals — the business is growing and cash-generative — but investors should be aware the reported/underlying gap is structural, not one-off.

Earnings vs. expectations

• March 2022: profit warning — Omicron impact + macro softness led to organic growth guidance downgrade to 5% for FY23; FY22 underlying PBT of £18m fell short of consensus (£20m).
• FY23 (Sept 2023): reported in line — underlying PBT £21.6m in line with revised expectations.
• FY24 (July 2024): solid recovery — underlying PBT £25.3m, up 11%, in line with market.
• FY25 (Sept 2025): in line — underlying PBT £28.0m, ~11% growth, with clean delivery.
• FY26 (July 2026): strong — 28% revenue growth, 19% underlying PBT growth; May 2026 trading update confirmed delivery in line with expectations.

Pattern: one meaningful miss (2022), then three consecutive years of in-line delivery. Track record is now solid but not a serial beater.

Conviction

3 — moderate

Anchoring factors: (i) five years of well-disclosed audited accounts with consistent presentation; (ii) transparent alternative performance measures reconciliation makes "underlying" vs "reported" gap analysable; (iii) three converging valuation approaches (multiple on underlying EPS, EV/EBITDA, sum-of-parts on completed and announced acquisitions) all land in a similar range.

Limiting factors: (i) the structural quantum of "non-underlying" costs (£11-18m annually) means picking the right adjusted earnings measure has a material impact on fair value — my range is wider than it would be for a cleaner business; (ii) the acquisition-led growth model depends on continued execution against a pipeline, and multiple compression on any slowdown could offset earnings growth.

Driver scoring rationale (brief)

• AI beneficiary 25: Legal services firm using AI defensively (security-first, own tools); no revenue uplift attributable to AI; lower-end conveyancing volume work theoretically substitutable. Not a picks-and-shovels beneficiary.
• Operating leverage 40: 61% employee cost ratio + variable staff base means limited fixed-cost leverage; margin actually declined 170bps despite 28% revenue growth in FY26.
• Earnings surprise trend 50: One profit warning (2022), three subsequent years in line — mixed but improving. "Not enough data" 50 with slight positive bias.
• Cyclicality 55: M&A, corporate transactions and residential conveyancing (Integrar) cyclical; private wealth, disputes, CL Medilaw less so. Moderately cyclical overall.
• Moat 30: Corporate scale advantages over independent partnerships is real but not deep; client relationships travel with fee earners; churn is a live risk.
• Leverage 45: Net debt £65.4m, 1.5x EBITDA banking covenant, RCF headroom £94m — moderate.
• Earnings quality 40: Cash conversion 163% is excellent, but the reported/underlying gap driven by ~£8m annual contingent consideration is a genuine economic cost that "underlying" hides.
• Management quality 55: Founder-CEO with 14-year corporatisation track record; delivered ~4x growth since IPO; related-party lease is a governance yellow flag.
• Growth momentum 65: 28% revenue growth, 12% H2 organic growth, healthy acquisition pipeline; but H1 organic growth only 2.6% shows lumpy delivery.

Overall score rationale

Fair-to-cheap valuation and decent growth momentum, but a weak fit against the investor's three pillars: essentially no AI beneficiary angle (services firm potentially exposed to AI substitution at the low end), only moderate operating leverage (people-heavy variable cost base), and adequate but not fortress balance sheet. A partial fit for the strategy — worth knowing at the price, not a focus name.